Detected ·
StimCardio Medical
$30MSeries A
StimCardio Medical raised an oversubscribed $30M Series A, with Catalyst Health Ventures joining the round and CHV Managing Partner Joshua Phillips joining the board. The funding will support the company's wrist-worn Rhyvive™ device for non-invasive nerve stimulation to reduce atrial fibrillation recurrence after catheter ablation, advancing its pivotal trial and FDA review preparations.
- Website
- —
- linkedin.com/company/28794323
- Amount
- $30 000 000 USD
- Stage
- Series A
- Event
- Funding round
- Detected
- 2026-11-03 20:13:40 UTC
- Signal ID
- ef5c5073-e65c-49c0-8709-944d19ea9343
As the API returns it
{
"id": "ef5c5073-e65c-49c0-8709-944d19ea9343",
"created_at": "2026-11-03T20:13:40.748494Z",
"company_name": "StimCardio Medical",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/28794323",
"event_type": "funding",
"funding_amount": 30000000,
"funding_currency": "USD",
"funding_stage": "series_a",
"message": "*StimCardio Medical raised an oversubscribed $30M Series A, with Catalyst Health Ventures joining the round and CHV Managing Partner Joshua Phillips joining the board. The funding will support the company's wrist-worn Rhyvive™ device for non-invasive nerve stimulation to reduce atrial fibrillation recurrence after catheter ablation, advancing its pivotal trial and FDA review preparations.*"
}